More Than A
Law Firm

Michael J. Duber and Brandon T. Duber

Onfi & Potiga Drugs Receive FDA Warning: Bentoff & Duber Medical Recall Recap

Dec 11, 2013 |

During the past month, the FDA has put out warnings about two different anti-seizure medications and Bentoff & Duber wants to make sure you are aware to help keep you safe, informed and proactive. If you or someone you know has been affected by one of these drugs, contact us.


After an FDA review of medical reports, the administration is now warning the public that the anti-seizure medication Onfi can cause severe skin reactions known as Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). These conditions can lead to permanent injury or even death.


The FDA issued a Safety Announcement warning doctors and patients that the anti-seizure drug Potiga can cause permanent vision loss and skin discoloration. Potiga is an anticonvulsant used as treatment for adults.

If you have suffered as a result of these drugs or any other pharmaceutical manufacturer negligence, we are here to take care of you. Call us today at 216-861-1234 or submit a contact form for a free consultation.


About the author: Brandon Duber, a Partner with Bentoff & Duber Co., LPA, is a lawyer with proven experience in the courtroom and expertise in the areas of workers’ compensation, criminal defense, personal injury and medical malpractice law. He received his B.A. from Skidmore College in Saratoga Springs, NY and his J.D. from The Case Western Reserve University School of Law in Cleveland, OH